440 results on '"Boletta A"'
Search Results
2. Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression
3. Fibrocystin/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis
4. Fibrocystin/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis
5. Primary cilia sense glutamine availability and respond via asparagine synthetase
6. Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
7. #2048 Exploring somatic mutation mechanisms in pre-cystic renal cells of autosomal dominant polycystic kidney disease patients
8. #1193 Tracking kidney cancer initiation via somatic mutation analysis of pre-cancer cells from Von Hippel Lindau cancer predisposition syndrome
9. Disruption of polycystin-1 cleavage leads to cardiac metabolic rewiring in mice
10. Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
11. Políticas públicas dos EUA e da China para a pandemia: tensões geopolíticas, competição tecnológica e modelos de desenvolvimento
12. Spatial metabolic tracing in the kidney — the future is now
13. In SILICO Simulations Predict a Causative Link Between Increased Glycolysis and Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease.
14. The Biogenesis of Polycystin 1 Requires Active AQP11 at the ER Membrane
15. Primary cilia sense glutamine availability and respond via asparagine synthetase
16. P1563: INTRACELLULAR IRON OVERLOAD IMPAIRS HSC FUNCTION BY AFFECTING MITOCHONDRIAL FITNESS IN ΒETA-THALASSEMIA
17. Mechanosensory Genes Pkd1 and Pkd2 Contribute to the Planar Polarization of Brain Ventricular Epithelium.
18. Reversing polycystic kidney disease
19. Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression
20. The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity
21. Metabolism and mitochondria in polycystic kidney disease research and therapy
22. Características do melanoma em idosos
23. Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC ‐driven lymphoma
24. Cleavage of Polycystin-1 Requires the Receptor for Egg Jelly Domain and Is Disrupted by Human Autosomal-Dominant Polycystic Kidney Disease 1-Associated Mutations
25. Polycystin-1 Regulates Actomyosin Contraction and the Cellular Response to Extracellular Stiffness
26. Oxidative stress enhances the therapeutic action of a respiratory inhibitor in <scp>MYC</scp> ‐driven lymphoma
27. The centrosomal OFD1 protein interacts with the translation machinery and regulates the synthesis of specific targets
28. Primary cilia sense glutamine availability and respond via asparagine synthetase.
29. mTORC1-driven accumulation of the oncometabolite fumarate as a potential critical step in renal cancer progression
30. Metabolic reprogramming in polycystic kidney disease explained by super-enhancers and CDK7: new therapeutic targets?
31. Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
32. Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
33. mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex
34. Targeting the Mitochondrial Protease Clpp Unveils Mitochondrial Vulnerabilities in Multiple Myeloma
35. Intracellular Iron Overload Induces Metabolic Switching in Active Hematopoietic Stem Cells in Beta-Thalassemia
36. Defective glycolysis and the use of 2-deoxy-d-glucose in polycystic kidney disease: from animal models to humans
37. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells
38. Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
39. Il Registro Italiano del Rene Policistico Autosomico Dominante
40. Role of the Polycystins in Cell Migration, Polarity, and Tissue Morphogenesis
41. Spatial metabolic tracing in the kidney — the future is now
42. P-109: ER-phagic control of lipid metabolism supports multiple myeloma cell survival
43. P-111: Targeting the mitochondrial protease ClpP unveils novel vulnerabilities in multiple myeloma
44. Role of the polycystins as mechanosensors of extracellular stiffness
45. Targeting the Mitochondrial Protease Clpp Unveils Mitochondrial Vulnerabilities in Multiple Myeloma
46. Intracellular Iron Overload Induces Metabolic Switching in Active Hematopoietic Stem Cells in Beta-Thalassemia
47. Oxidative stress potentiates the therapeutic action of a mitochondrial complex I inhibitor in MYC-driven B-cell lymphoma
48. Oxidative stress potentiates the therapeutic action of a mitochondrial complex I inhibitor in MYC-driven B-cell lymphoma
49. P1563: INTRACELLULAR IRON OVERLOAD IMPAIRS HSC FUNCTION BY AFFECTING MITOCHONDRIAL FITNESS IN ΒETA-THALASSEMIA
50. Characterization of the PKD 1 Gene Product, Polycystin-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.